Epigenomics Ag Stock Probability of Future Pink Sheet Price Finishing Under 2.89
| EPGNF Stock | USD 0.50 2.00 80.00% |
Epigenomics |
Epigenomics Target Price Odds to finish below 2.89
The tendency of Epigenomics Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 2.89 after 90 days |
| 0.50 | 90 days | 2.89 | close to 99 |
Based on a normal probability distribution, the odds of Epigenomics to stay under $ 2.89 after 90 days from now is close to 99 (This Epigenomics AG probability density function shows the probability of Epigenomics Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Epigenomics AG price to stay between its current price of $ 0.50 and $ 2.89 at the end of the 90-day period is about 56.81 .
Assuming the 90 days horizon Epigenomics AG has a beta of -9.43 suggesting as returns on its benchmark rise, returns on holding Epigenomics AG are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Epigenomics is expected to outperform its benchmark. In addition to that Epigenomics AG has an alpha of 10.4343, implying that it can generate a 10.43 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta). Epigenomics Price Density |
| Price |
Predictive Modules for Epigenomics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Epigenomics AG. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Epigenomics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Epigenomics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Epigenomics is not an exception. The market had few large corrections towards the Epigenomics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Epigenomics AG, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Epigenomics within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | 10.43 | |
β | Beta against NYSE Composite | -9.43 | |
σ | Overall volatility | 0.35 | |
Ir | Information ratio | 0.14 |
Epigenomics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Epigenomics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Epigenomics AG can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Epigenomics AG is way too risky over 90 days horizon | |
| Epigenomics AG has some characteristics of a very speculative penny stock | |
| Epigenomics AG appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 6.2 M. Net Loss for the year was (2.43 M) with profit before overhead, payroll, taxes, and interest of 6.07 M. | |
| Epigenomics AG has accumulated about 15.77 M in cash with (4.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 35.0% of the company shares are held by company insiders |
Epigenomics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Epigenomics Pink Sheet often depends not only on the future outlook of the current and potential Epigenomics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Epigenomics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 15.5 M |
Epigenomics Technical Analysis
Epigenomics' future price can be derived by breaking down and analyzing its technical indicators over time. Epigenomics Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Epigenomics AG. In general, you should focus on analyzing Epigenomics Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Epigenomics Predictive Forecast Models
Epigenomics' time-series forecasting models is one of many Epigenomics' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Epigenomics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Epigenomics AG
Checking the ongoing alerts about Epigenomics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Epigenomics AG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Epigenomics AG is way too risky over 90 days horizon | |
| Epigenomics AG has some characteristics of a very speculative penny stock | |
| Epigenomics AG appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 6.2 M. Net Loss for the year was (2.43 M) with profit before overhead, payroll, taxes, and interest of 6.07 M. | |
| Epigenomics AG has accumulated about 15.77 M in cash with (4.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 35.0% of the company shares are held by company insiders |
Check out Epigenomics Backtesting, Epigenomics Valuation, Epigenomics Correlation, Epigenomics Hype Analysis, Epigenomics Volatility, Epigenomics History as well as Epigenomics Performance. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Epigenomics Pink Sheet analysis
When running Epigenomics' price analysis, check to measure Epigenomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Epigenomics is operating at the current time. Most of Epigenomics' value examination focuses on studying past and present price action to predict the probability of Epigenomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Epigenomics' price. Additionally, you may evaluate how the addition of Epigenomics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |